RadioTherapeutics targets RF (radiofrequency) system on liver lesions
This article was originally published in Clinica
Executive Summary
RadioTherapeutics, manufacturer of a radiofrequency system (RF) for ablating soft tissues, has received additional 510(k) clearance from the US FDA to market the product specifically for ablating liver lesions.